State Street Health Care Select Sector SPDR ETF (XLV)
Market Price (6/16/2026): $153.47
State Street Health Care Select Sector SPDR ETF (XLV)
Market Price (6/16/2026): $153.47
Key Takeaways
- XLV has returned -0.8% YTD vs +11.0% for SPY; +14.3% over the past 12 months (SPY +27.9%). details →
- Priced in gold, XLV has returned -43.4% over the past 3 years, vs +21.6% in dollars — its dollar gains have lagged gold. details →
- Risk-adjusted returns trail SPY: 3-year Sharpe ratio of 0.3 vs 1.2. details →
- XLV's top 10 holdings represent 61% of the fund vs 38% for SPY — a more concentrated portfolio. details →
- XLV's portfolio trades at 17.3x forward earnings — a 15% discount to SPY (20.4x). details →
Asset Allocation with XLV
Valuation & Yield
| Forward [4,5] | Now | Historical (CYE & TTM) | |||||
|---|---|---|---|---|---|---|---|
| 6/30/27 | 6/16/26 | 2025 | 2024 | 2023 | 2022 | 2021 | |
| Share Price CYE | $152.89 | $154.17 | $134.64 | $131.39 | $128.73 | $131.46 | |
| Dividend/Share TTM | $2.51 | $2.48 | $2.29 | $2.17 | $1.99 | $1.87 | |
Valuation [1] | |||||||
| P/S | 1.44 | 1.52 | 1.57 | 1.55 | 1.70 | 1.84 | 2.13 |
| P/E | 28.27 | 27.71 | 30.48 | 27.41 | 23.28 | 24.17 | |
| P/E (Non-GAAP) [2] | 17.26 | 19.10 | 19.80 | 20.34 | 35.06 | 24.43 | 25.86 |
| P/FCF | 22.87 | 24.49 | 24.44 | 23.76 | 20.16 | 19.42 | |
Yields TTM | |||||||
| Earnings Yield | 5.79% | 3.54% | 3.61% | 3.28% | 3.65% | 4.30% | 4.14% |
| Dividend Yield | 1.64% | 1.64% | 1.61% | 1.70% | 1.65% | 1.55% | 1.42% |
| Total Yield (TY) | 7.43% | 5.18% | 5.21% | 4.98% | 5.30% | 5.84% | 5.56% |
Risk Premium [3] | |||||||
| Risk Free Rate (Rf) | 4.48% | 4.48% | 4.18% | 4.58% | 3.88% | 3.88% | 1.52% |
| Risk Prem. (TY - Rf) | 2.95% | 0.70% | 1.03% | 0.40% | 1.42% | 1.96% | 4.04% |
Growth Rates [6] | |||||||
| Sales Growth | 5.0% | 1.7% | 10.2% | 8.4% | 6.1% | 8.7% | |
| Earnings Growth [7] | 13.5% | -2.8% | 25.1% | -15.1% | -16.6% | -1.9% | |
[1] P/E uses the aggregate method over profitable constituents; P/FCF aggregates net free cash flow across all constituents (negative-FCF names reduce it); P/S uses all constituents. Ratios reflect current ETF holdings at current weights. P/FCF has no Forward column (no analyst FCF estimate).
[2] P/E (Non-GAAP) uses analyst consensus net income (adjusted basis) for all periods. The standard P/E row above uses GAAP net income.
[3] The premium above the risk free rate (US 10Y) offered by the investment. Negative premiums can indicate stretched valuations.
Show more
Top 20 Holdings for XLV
Total Weights Top 5: 46.0% | Top 10: 60.9% | Top 20: 80.4%
| Ticker | Holding | ETF Weight | Sales Weight | Earnings Weight | Fwd P/S | Fwd P/E | Fwd Sales Growth | Fwd Earnings Growth |
|---|---|---|---|---|---|---|---|---|
| Total | 99.78% | 100.00% | 100.00% | 1.4 | 17.3 | +5.0% | +13.5% | |
| Top 20 | 80.41% | 66.03% | 77.36% | 1.8 | 17.8 | +4.9% | +14.2% | |
| LLY | Eli Lilly | 16.53% | 1.80% | 11.71% | 11.0 | 29.4 | +15.9% | +22.1% |
| JNJ | Johnson & Johnson | 10.32% | 2.67% | 10.83% | 5.4 | 19.0 | +6.8% | +11.1% |
| ABBV | AbbVie | 7.14% | 1.75% | 1.87% | 5.6 | 14.3 | +8.1% | +14.3% |
| UNH | UnitedHealth | 6.60% | 12.14% | 6.03% | 0.8 | 21.4 | +2.8% | +6.7% |
| MRK | Merck | 5.38% | 1.90% | 4.80% | 4.2 | 15.3 | +5.2% | +86.9% |
| AMGN | Amgen | 3.42% | 1.03% | 4.00% | 4.9 | 15.6 | +2.6% | +4.4% |
| TMO | Thermo Fisher Scientific | 3.21% | 1.26% | 3.53% | 3.6 | 17.8 | +5.4% | +8.2% |
| GILD | Gilead Sciences | 2.81% | 0.83% | 4.74% | 4.9 | 26.8 | +6.5% | — |
| ABT | Abbott Laboratories | 2.80% | 1.25% | 3.22% | 2.9 | 15.3 | +9.0% | +10.6% |
| PFE | Pfizer | 2.67% | 1.75% | 3.83% | 2.4 | 9.1 | -4.1% | -6.1% |
| ISRG | Intuitive Surgical | 2.63% | 0.29% | 1.50% | 11.9 | 36.8 | +13.5% | +14.0% |
| CVS | CVS Health | 2.30% | 11.16% | 1.49% | 0.3 | 12.7 | +4.4% | +12.1% |
| BMY | Bristol-Myers Squibb | 2.08% | 1.34% | 3.74% | 2.4 | 9.0 | -2.1% | -5.0% |
| DHR | Danaher | 2.04% | 0.60% | 1.67% | 4.9 | 20.5 | +6.1% | +8.2% |
| VRTX | Vertex Pharmaceuticals | 2.03% | 0.33% | 2.18% | 8.4 | 21.6 | +9.5% | +13.4% |
| SYK | Stryker | 1.89% | 0.62% | 1.52% | 4.1 | 19.7 | +8.5% | +8.8% |
| MDT | Medtronic | 1.85% | 0.97% | 2.35% | 2.6 | 13.2 | +2.8% | +6.6% |
| MCK | McKesson | 1.73% | 11.18% | 2.45% | 0.2 | 16.8 | +7.2% | +13.9% |
| ELV | Elevance Health | 1.58% | 5.48% | 2.66% | 0.4 | 14.0 | +2.4% | +11.1% |
| CI | Cigna | 1.40% | 7.67% | 3.22% | 0.3 | 9.1 | +4.3% | +9.3% |
[2] Forward P/S and P/E ratios use consensus sales and earnings for the 12 months ending 6/30/27. Individual constituent FY1 and FY2 consensus figures adjusted to align with 6/30/27.
[3] Forward Sales and Non-GAAP Earnings Growth are calculated as next fiscal year (FY2) consensus growth over current fiscal year (FY1) consensus. They are not derived from the forward P/S and P/E multiples shown.
Performance for XLV Top Holdings
| Ticker | Holding | Weight | Mkt Price6/15 | 1D Rtn | 1M Rtn | YTD Rtn | 1Y Rtn | 3Y Rtn | 5Y Rtn | 10Y Rtn |
|---|---|---|---|---|---|---|---|---|---|---|
| XLV | State Street Health Care Select Sector SPDR ETF | 100.00% | 152.89 | -0.6% | 5.4% | -0.8% | 14.3% | 21.6% | 33.4% | 157.9% |
| LLY | Eli Lilly | 16.53% | 1,129.35 | -0.3% | 12.4% | 5.4% | 38.8% | 157.7% | 436.3% | 1,696.9% |
| JNJ | Johnson & Johnson | 10.32% | 235.66 | -2.2% | 4.5% | 15.1% | 53.8% | 56.6% | 65.0% | 168.3% |
| ABBV | AbbVie | 7.14% | 221.59 | -2.7% | 5.3% | -1.4% | 19.7% | 78.0% | 131.4% | 457.6% |
| UNH | UnitedHealth | 6.60% | 411.04 | 1.2% | 5.0% | 26.2% | 35.6% | -4.7% | 13.4% | 252.1% |
| MRK | Merck | 5.38% | 114.90 | -2.8% | 3.9% | 10.8% | 46.8% | 15.3% | 75.3% | 192.6% |
| AMGN | Amgen | 3.42% | 350.53 | -1.3% | 7.4% | 8.7% | 22.3% | 67.4% | 71.3% | 218.1% |
| TMO | Thermo Fisher Scientific | 3.21% | 473.72 | 1.0% | 8.2% | -18.1% | 18.0% | -11.0% | 2.6% | 233.3% |
| GILD | Gilead Sciences | 2.81% | 124.30 | -0.4% | -3.4% | 2.5% | 16.0% | 74.0% | 121.6% | 114.3% |
| ABT | Abbott Laboratories | 2.80% | 88.67 | 0.6% | 5.0% | -28.4% | -33.3% | -11.3% | -11.5% | 186.0% |
| PFE | Pfizer | 2.67% | 26.00 | -0.8% | 2.6% | 7.9% | 13.4% | -21.8% | -14.5% | 18.6% |
| ISRG | Intuitive Surgical | 2.63% | 416.55 | 1.3% | -1.1% | -26.5% | -18.7% | 26.5% | 43.4% | 484.2% |
| CVS | CVS Health | 2.30% | 100.68 | -1.3% | 5.0% | 29.0% | 54.7% | 67.0% | 40.2% | 44.3% |
| BMY | Bristol-Myers Squibb | 2.08% | 56.24 | -1.6% | -1.3% | 6.6% | 18.7% | -2.3% | 2.7% | 12.5% |
| DHR | Danaher | 2.04% | 181.10 | 0.6% | 11.9% | -20.7% | -9.1% | -14.3% | -14.8% | 188.7% |
| VRTX | Vertex Pharmaceuticals | 2.03% | 450.46 | 1.2% | 3.1% | -0.6% | -1.1% | 29.5% | 140.3% | 419.4% |
| SYK | Stryker | 1.89% | 307.94 | -1.4% | 0.4% | -12.1% | -17.6% | 7.7% | 26.5% | 200.9% |
| MDT | Medtronic | 1.85% | 80.38 | 0.2% | 5.6% | -15.6% | -5.0% | -0.6% | -25.1% | 24.2% |
| MCK | McKesson | 1.73% | 779.78 | -0.5% | 2.6% | -4.8% | 7.5% | 94.3% | 318.0% | 373.9% |
| ELV | Elevance Health | 1.58% | 401.89 | -0.5% | 2.8% | 15.8% | 6.7% | -4.8% | 14.1% | 248.8% |
| CI | Cigna | 1.40% | 293.83 | -1.4% | 3.6% | 8.0% | -5.4% | 15.7% | 35.9% | 151.1% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| XLV Return | 26% | -2% | 2% | 2% | 15% | -0% | 47% |
| Peers Return | 35% | -2% | 28% | 21% | 18% | 19% | 186% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 9% | 98% |
Monthly Win Rates [3] | |||||||
| XLV Win Rate | 75% | 42% | 50% | 67% | 58% | 50% | |
| Peers Win Rate | 70% | 42% | 62% | 62% | 65% | 47% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| XLV Max Drawdown | -8% | -16% | -9% | -13% | -14% | -10% | |
| Peers Max Drawdown | -11% | -28% | -14% | -12% | -21% | -13% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: VGT, XLK, XLF, XLE, XLI.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 6/15/2026 (YTD)
Sharpe Ratios Compared
One measure of reward vs. risk is a Sharpe ratio. A higher ratio indicates better risk-adjusted returns. Most funds have Sharpe ratios < 1.0.
Results as of 5312026.How Low Can It Go
| Event | XLV | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -11.7% | -18.8% |
| % Gain to Breakeven | 13.3% | 23.1% |
| Time to Breakeven | 142 days | 79 days |
| 2022 Inflation Shock & Fed Tightening | ||
| % Loss | -13.8% | -24.5% |
| % Gain to Breakeven | 15.9% | 32.4% |
| Time to Breakeven | 166 days | 427 days |
| 2020 COVID-19 Crash | ||
| % Loss | -27.9% | -33.7% |
| % Gain to Breakeven | 38.8% | 50.9% |
| Time to Breakeven | 77 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -15.0% | -19.2% |
| % Gain to Breakeven | 17.6% | 23.8% |
| Time to Breakeven | 191 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -15.9% | -12.2% |
| % Gain to Breakeven | 18.9% | 13.9% |
| Time to Breakeven | 165 days | 62 days |
| 2011 US Debt Ceiling Crisis & European Contagion | ||
| % Loss | -15.8% | -17.9% |
| % Gain to Breakeven | 18.8% | 21.8% |
| Time to Breakeven | 153 days | 123 days |
In The Past
State Street Health Care Select Sector SPDR ETF's stock fell -11.7% during the 2025 US Tariff Shock. Such a loss loss requires a 13.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | XLV | S&P 500 |
|---|---|---|
| 2020 COVID-19 Crash | ||
| % Loss | -27.9% | -33.7% |
| % Gain to Breakeven | 38.8% | 50.9% |
| Time to Breakeven | 77 days | 140 days |
| 2008-2009 Global Financial Crisis | ||
| % Loss | -37.9% | -53.4% |
| % Gain to Breakeven | 61.1% | 114.4% |
| Time to Breakeven | 767 days | 1085 days |
In The Past
State Street Health Care Select Sector SPDR ETF's stock fell -11.7% during the 2025 US Tariff Shock. Such a loss loss requires a 13.3% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Current Dip Buy Opportunities Across ETFs
ETFs currently down 5% or more from trailing 6M peaks.
| Ticker | Name | Dip % | Mkt Price | Price Date | Peak Price | Peak Date | # Days |
|---|---|---|---|---|---|---|---|
| MAGS | Roundhill Magnificent Seven ETF | -6.1% | 66.62 | 6152026 | 70.94 | 5142026 | 32 |
| AKRE | Akre Focus ETF | -17.9% | 54.68 | 6152026 | 66.59 | 1062026 | 160 |
| EWZ | iShares MSCI Brazil ETF | -17.0% | 34.64 | 6152026 | 41.73 | 4142026 | 62 |
| FXI | iShares China Large-Cap ETF | -13.9% | 35.11 | 6152026 | 40.78 | 1292026 | 137 |
| ILF | iShares Latin America 40 ETF | -9.7% | 34.41 | 6152026 | 38.10 | 4142026 | 62 |
| KWEB | KraneShares CSI China Internet ETF | -29.3% | 26.62 | 6152026 | 37.66 | 1122026 | 154 |
| URA | Global X Uranium ETF | -22.2% | 48.06 | 6152026 | 61.81 | 1282026 | 138 |
| BOTZ | Global X Funds Global X Robotics & Artificial Intelligence ETF | -8.1% | 38.25 | 6152026 | 41.63 | 5132026 | 33 |
| ROBO | ROBO Global Robotics & Automation Index ETF | -5.7% | 85.21 | 6152026 | 90.34 | 6022026 | 13 |
| LIT | Global X Lithium & Battery Tech ETF | -8.2% | 84.08 | 6152026 | 91.62 | 5112026 | 35 |
| ICLN | iShares Global Clean Energy ETF | -11.5% | 21.03 | 6152026 | 23.75 | 6022026 | 13 |
| ARKQ | ARK Autonomous Technology & Robotics ETF | -6.3% | 134.69 | 6152026 | 143.82 | 5282026 | 18 |
| ARKW | ARK Next Generation Internet ETF | -5.4% | 147.44 | 6152026 | 155.78 | 12222025 | 175 |
| ARKX | ARK Space & Defense Innovation ETF | -6.8% | 35.18 | 6152026 | 37.74 | 5282026 | 18 |
| NASA | Tema Space Innovators ETF | -22.5% | 32.48 | 6152026 | 41.89 | 5272026 | 19 |
| CGBL | Capital Group Core Balanced ETF | -6.2% | 34.41 | 6152026 | 36.67 | 2252026 | 110 |
| GDE | WisdomTree Efficient Gold Plus Equity Strategy Fund | -6.7% | 65.67 | 6152026 | 70.39 | 5112026 | 35 |
| XLE | State Street Energy Select Sector SPDR ETF | -11.2% | 55.55 | 6152026 | 62.56 | 3292026 | 78 |
| XLC | State Street Communication Services Select Sector SPDR ETF | -6.3% | 112.19 | 6152026 | 119.70 | 2012026 | 134 |
| XLU | State Street Utilities Select Sector SPDR ETF | -5.6% | 44.74 | 6152026 | 47.40 | 3012026 | 106 |
| FXN | First Trust Energy AlphaDEX Fund | -9.9% | 20.89 | 6152026 | 23.18 | 3292026 | 78 |
| ITA | iShares U.S. Aerospace & Defense ETF | -5.2% | 237.40 | 6152026 | 250.42 | 3022026 | 105 |
| XOP | State Street SPDR S&P Oil & Gas Exploration & Production ETF | -15.8% | 158.36 | 6152026 | 188.18 | 3292026 | 78 |
| IGV | iShares Expanded Tech-Software Sector ETF | -14.9% | 92.68 | 6152026 | 108.95 | 12222025 | 175 |
| MISL | First Trust Indxx Aerospace & Defense ETF | -8.1% | 46.87 | 6152026 | 50.98 | 1192026 | 147 |
| RING | iShares MSCI Global Gold Miners ETF | -26.2% | 73.41 | 6152026 | 99.42 | 3012026 | 106 |
| EDV | Vanguard World Funds Extended Duration ETF | -6.2% | 64.11 | 6152026 | 68.33 | 3012026 | 106 |
| PDBC | Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF | -10.7% | 16.89 | 6152026 | 18.91 | 5122026 | 34 |
| DBC | Invesco DB Commodity Index Tracking Fund | -10.9% | 28.22 | 6152026 | 31.69 | 5122026 | 34 |
| COMT | iShares GSCI Commodity Dynamic Roll Strategy ETF | -12.2% | 32.06 | 6152026 | 36.53 | 5192026 | 27 |
| GSG | iShares GSCI Commodity | -5.8% | 30.01 | 6152026 | 31.85 | 3182026 | 89 |
| BCI | abrdn Bloomberg All Commodity Strategy K-1 Free ETF | -10.3% | 23.25 | 6152026 | 25.91 | 5122026 | 34 |
| FTGC | First Trust Global Tactical Commodity Strategy Fund | -8.9% | 27.82 | 6152026 | 30.53 | 5122026 | 34 |
| HGER | Harbor Commodity All-Weather Strategy ETF | -9.9% | 30.17 | 6152026 | 33.47 | 5122026 | 34 |
| GLD | SPDR Gold Trust | -20.0% | 396.55 | 6152026 | 495.90 | 1292026 | 137 |
| IAU | iShares Gold Trust | -20.0% | 81.26 | 6152026 | 101.57 | 1292026 | 137 |
| GLDM | SPDR Gold MiniShares Trust | -19.9% | 85.51 | 6152026 | 106.77 | 1292026 | 137 |
| SGOL | ETFS Physical Swiss Gold Shares | -13.1% | 44.66 | 6152026 | 51.41 | 1292026 | 137 |
| BAR | Direxion Daily Gold Bull 3X Shares | -16.6% | 44.34 | 6152026 | 53.16 | 1292026 | 137 |
| SLV | iShares Silver Trust | -39.9% | 63.47 | 6152026 | 105.60 | 1282026 | 138 |
| SIVR | ETFS Physical Silver Shares Trust ETF | -24.8% | 83.39 | 6152026 | 110.87 | 1282026 | 138 |
| PPLT | ETFS Physical Platinum Shares | -36.3% | 16.06 | 6152026 | 25.23 | 1252026 | 141 |
| CPER | United States Copper Index Fund ETV | -13.9% | 33.33 | 6152026 | 38.71 | 1292026 | 137 |
| PALL | ETFS Physical Palladium Shares | -34.4% | 24.40 | 6152026 | 37.18 | 1282026 | 138 |
| USO | United States Oil Fund LP | -20.8% | 121.21 | 6152026 | 152.96 | 5192026 | 27 |
| UNG | United States Natural Gas Fund LP | -32.4% | 11.43 | 6152026 | 16.90 | 2012026 | 134 |
| BNO | United States Brent Oil Fund LP ETV | -7.1% | 55.85 | 6152026 | 60.13 | 5042026 | 42 |
| IBIT | iShares Bitcoin Trust ETF | -31.9% | 37.74 | 6152026 | 55.44 | 1142026 | 152 |
| FBTC | Fidelity Wise Origin Bitcoin Fund | -31.9% | 57.96 | 6152026 | 85.12 | 1142026 | 152 |
| GBTC | Grayscale Bitcoin Trust ETF | -19.0% | 61.84 | 6152026 | 76.31 | 1142026 | 152 |
| ETHA | iShares Ethereum Trust ETF | -46.2% | 13.76 | 6152026 | 25.59 | 1142026 | 152 |
ETF Fund Flows
Largest fund inflows and outflows across ETFs, with the asset-allocation rotation they imply.
Asset allocation rotation · Past month
- Equity ETFs drew the largest net inflows (+$38.5B), followed by Bond (+$23.3B), while Crypto (−$5.1B) and Commodity (−$4.9B) saw the largest outflows.
- Within the mix, money rotated into US Nasdaq Growth (+$9.5B) and out of Emerging Markets (−$5.3B).
- Relative to fund size, NASA drew the largest inflow (+115.4% of AUM) and THRO the largest outflow (−38.8%).
| # | Ticker | Name | Net flow | % of AUM |
|---|---|---|---|---|
| 1 | VOO | Vanguard S&P 500 ETF | +$20.52B | +2.1% |
| 2 | SPY | State Street SPDR S&P 500 ETF Trust | +$16.79B | +2.2% |
| 3 | SGOV | iShares 0-3 Month Treasury Bond ETF | +$6.23B | +6.8% |
| 4 | QQQ | Invesco QQQ Trust, Series 1 | +$5.11B | +1.1% |
| 5 | DRAM | Roundhill Memory ETF | +$5.07B | +33.7% |
| 6 | IUSB | iShares Core Universal USD Bond ETF | +$4.98B | +12.0% |
| 7 | SOXX | iShares Semiconductor ETF | +$4.4B | +11.5% |
| 8 | VHT | Vanguard Health Care ETF | +$4.38B | +26.7% ⚠ |
| 9 | QQQM | Invesco NASDAQ 100 ETF | +$4.12B | +4.3% |
| 10 | VTI | Vanguard Total Stock Market ETF | +$3.65B | +0.6% |
| # | Ticker | Name | Net flow | % of AUM |
|---|---|---|---|---|
| 1 | IVV | iShares Core S&P 500 ETF | -$33.76B | -4.1% |
| 2 | QUAL | iShares MSCI USA Quality Factor ETF | -$6.96B | -15.0% |
| 3 | EFV | iShares MSCI EAFE Value ETF | -$5.48B | -19.8% |
| 4 | IBIT | iShares Bitcoin Trust ETF | -$3.74B | -6.7% |
| 5 | GLD | SPDR Gold Shares | -$3.34B | -2.3% |
| 6 | TLT | iShares 20+ Year Treasury Bond ETF | -$2.97B | -7.1% |
| 7 | IVE | iShares S&P 500 Value ETF | -$2.79B | -5.8% |
| 8 | THRO | iShares U.S. Thematic Rotation Active ETF | -$2.63B | -38.8% |
| 9 | IAGG | iShares Core International Aggregate Bond ETF | -$2.6B | -23.0% |
| 10 | XLF | State Street Financial Select Sector SPDR ETF | -$1.16B | -2.3% |
Largest ETF fund flows across ~2447 funds (min AUM $100M). Net creations/redemptions; leveraged & inverse ETFs excluded. A ⚠ marks a day excluded as a suspected data error.
About XLV
| Holdings Count: 60Expense Ratio: 0.08%Inception Date: 1998-12-16 | State Street Health Care Select Sector SPDR ETFThe State Street Health Care Select Sector SPDR ETF (XLV) is designed to reflect, before expenses, the price and yield performance of the Health Care Select Sector Index. This benchmark offers a clear representation of the healthcare industry within the S&P 500. The fund provides focused exposure to companies across diverse healthcare fields, such as pharmaceuticals, medical equipment and supplies, healthcare providers and services, biotechnology, life sciences tools and services, and health technology. It allows investors to make targeted strategic or tactical allocations that are more precise than those offered by traditional style-based investment vehicles.Asset Class: Equity | ETF Website |
Research & Analysis
Invest in Strategies
Wealth Management
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.